LDS Hospital
Salt Lake City, Utah, 84143, United States
NCT Number: NCT02593916
To create a registry/database of patients who either have taken drugs that treat cardiovascular conditions or that have presented with cardiovascular symptoms that may be related to medication.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Salt Lake City, Utah, 84143, United States
To create a registry/database of patients who either have taken drugs that treat cardiovascular conditions or that have presented with cardiovascular symptoms that may be related to medication. Potential enrollees are those receiving (presently or in the past) the medicine(s) of interest. Subjects will be identified from computerized Intermountain Healthcare records. Patients receiving a drug of interest, both with and without an ADE will be enrolled in approximately equal numbers. Outpatients will be contacted by mail and invited to participate. Interested subjects will be instructed to return the enclosed response card with their intent indicated. The registry coordinator will contact interested subjects and the project will be explained. Willing participants will be enrolled either in person or via mail with the assistance of the project coordinator. Persons presenting in person for enrollment will be given the choice of venipuncture or buccal swab for sample collection for DNA extraction. In all cases informed consent will be obtained before collecting samples.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
We will monitor clinical responses to medications for 5 years and look for genetic markers and biomarkers that correlate with these responses.
Time frame: 5 years
We will monitor medication dosage adjustments for 5 years and look for genetic markers and biomarkers that correlate with these adjustments.
Time frame: 5 years
We will monitor beneficial responses to medications for 5 years and look for genetic markers and biomarkers that correlate with these responses.
Time frame: 5 years
We will monitor adverse drug events for 5 years and look for genetic markers and biomarkers that correlate with these events.
Time frame: 5 years
We will monitor drug interactions for 5 years and look for genetic markers and biomarkers that correlate with these interactions.
Intermountain Health Care, Inc.
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01091038
Adverse Drug Events, Chemically-Induced Disorders
Indianapolis, Indiana, United States
View Trial DetailsNCT04692220
Adverse Drug Events, Chemically-Induced Disorders
Montpellier, France
View Trial DetailsNCT02482025
Adverse Drug Events, Chemically-Induced Disorders
Boston, Massachusetts, United States
View Trial DetailsNCT02059044
Adverse Drug Events, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details